| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 81.818 | 77.083 | 68.138 | 22.285 | 33.914 | 18.900 | 24.716 | 20.383 | 5.997 | 8.715 |
| Total Income - EUR | 89.472 | 84.348 | 68.138 | 22.531 | 34.443 | 18.915 | 24.716 | 20.809 | 5.997 | 8.715 |
| Total Expenses - EUR | 49.816 | 12.486 | 11.024 | 14.240 | 14.513 | 18.217 | 17.681 | 24.622 | 16.683 | 13.339 |
| Gross Profit/Loss - EUR | 39.657 | 71.862 | 57.114 | 8.291 | 19.930 | 698 | 7.035 | -3.812 | -10.686 | -4.625 |
| Net Profit/Loss - EUR | 33.265 | 70.175 | 56.433 | 8.065 | 19.585 | 509 | 6.838 | -4.020 | -10.748 | -4.712 |
| Employees | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bio Group S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.717 | 11.565 | 11.369 | 11.806 | 11.718 | 8.416 | 5.421 | 2.619 | 0 | 0 |
| Current Assets | 364.655 | 86.622 | 94.578 | 74.362 | 43.667 | 18.827 | 29.987 | 24.190 | 16.012 | 12.449 |
| Inventories | 108 | 11.192 | 10.378 | 10.187 | 8.922 | 7.306 | 7.144 | 7.166 | 3.758 | 3.040 |
| Receivables | 20.119 | 41.412 | 27.439 | 20.984 | 6.783 | 2.317 | 3.776 | 4.139 | 822 | 891 |
| Cash | 172.914 | 34.017 | 56.761 | 43.191 | 27.962 | 9.204 | 19.067 | 12.886 | 11.431 | 8.518 |
| Shareholders Funds | 368.396 | 70.442 | 56.696 | 63.720 | 27.748 | 757 | 7.578 | -3.278 | -14.016 | -18.649 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 7.975 | 27.745 | 49.252 | 22.665 | 28.067 | 26.999 | 28.205 | 30.087 | 30.028 | 31.098 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4669 - 4669" | |||||||||
| CAEN Financial Year |
4669
|
|||||||||
Comments - Bio Group S.r.l.